Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract

Histopathology

Volumn 28, Issue 2, 1996, Pages 111-120

  Kobashi, Y ^a   Nakamura, S ^b   Sasajima, Y ^c   Koshikawa, T ^b   Yatabe, Y ^b   Kitoh, K ^b   Mori, S ^c   Ueda, R ^b   Yamabe, H ^d   Suchi, T ^b  

^a TENRI HOSPITAL   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Angiocentric lymphoma; Blastic NK cell lymphoma; CD56 (NCAM); Epstein Barr virus; Natural killer cell

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN;

ADULT; AGED; ARTICLE; BONE MARROW; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY; LYMPH NODE; LYMPHOMA; MALE; MUSCLE; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECTUM; SKIN; SPLEEN;

EID: 9044240870     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.278324.x     Document Type: Article

References (69)

1. Gaffey MJ, Weiss LM. Viral oncogenesis: Epstein-Barr virus. Am J. Otolaryngol. 1990; 1;375-381.
2. Jones JF, Shurin S, Abramowsky C et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N. Engl. J. Med. 1988; 318;733-741.
3. Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in clinical specimens. Am. J. Pathol. 1994; 145;239-252.
4. Oshima K, Kikuchi M, Eguchi F et al. Analysis of Epstein-Barr viral genomes using Southern blotting, polymerase chain reaction and in situ hybridization. Virchows. Arch. [B] 1990; 59;383-390.
5. Su I-J, Hsieh H-C, Lin K-H et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 1991; 77;799-808.
6. Hamilton-Dutoit SJ, Pallesen G. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am. J. Pathol. 1992; 140;1315-1325
7. Ott G, Ott MM, Feller AC, Seidl S, Müller-Hermelink HK. Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population. Int. J. Cancer 1992; 51;562-567.
8. Tokunaga M, Imai S, Uemura Y, Tokudome T, Osato T, Sato W. Epstein-Barr virus in adult T-cell leukemia/lymphoma. Am. J. Pathol. 1993; 143;1263-1269.
9. Harabuchi Y, Yamanaka N, Kataura A et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335;128-130.
10. Ho FC, Srivastava G, Loke SI, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type. Hematol. Oncol. 1990; 8;271-281.
11. Weiss LM, Gaffey MJ, Chen YY, Frierson HF. Frequency of Epstein-Barr viral DNA in "Western" sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am. J. Surg. Pathol. 1992; 16;156-162.
12. Medeiros LJ, Jaffe ES, Chen YY, Weiss LM. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am. J. Surg. Pathol. 1992; 16;439-447.
13. Kanavaros P, Lescs M-C, Brière J et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81;2688-2695.
14. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am. J. Surg. Pathol. 1993; 17;392-399.
15. Korbjuhn P, Anagnostopoulos I, Hummell M et al. Frequent latent Epstein-Barr virus infection of neoplastic T-cells and bystander B-cells in HIV-negative European peripheral pleomorphic T-cell lymphomas. Blood 1993; 82;217-223.
16. Borisch B, Henning I, Laeng RH, Waelti ER, Kraft R, Laissure J. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 1993; 82;858-864.
17. Meneses MF, Weiss LM, Ilstrup DM, Cupps RE, DeRemee RA, Strickler JC. "Polymorphic reticulosis" of the upper aerodigestive tract [Abstract]. Mod. Pathol. 1993; 65;6A
18. Strickler JG, Meneses MF, Habermann TM et al. Polymorphic reticulosis: a reappraisal. Hum. Pathol. 1994; 25;659-665.
19. Chan JKC, Yip TTC, Tsang WYW et al. Detection of Epstein-Barr Viral RNA in malignant lymphomas of the upper aerodigestive tract. Am. J. Surg. Pathol. 1994; 18;938-946.
20. Eichel BS, Harrison EG, Devine KD, Scanlon PW, Brown HA. Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am. J. Surg. 1966; 112;597-605.
21. DeRemee RA, Weiland LH, McDonald TJ. Polymorphic reticulosis, lymphomatoid granulomatosis. Two diseases or one? Mayo Clin. Proc. 1978; 53;634-640.
22. Ishii Y, Yamanaka N, Ogawa K, Yoshida Y, Takami T, Matsuura A. T-cell lymphoma as a type of so-called "lethal midline granuloma." Cancer 1982; 50;2336-2344.
23. Jaffe ES. Post-thymic lymphoid neoplasia. In Jaffe ES ed. Surgical Pathology of the Lymph Nodes and Related Organs, Major Problems in Pathology, Vol 16. Philadelphia: EB Saunders, 1985; 218-248.
24. Yamanaka N, Harabuchi Y, Sambe S et al. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity, clinical and immunologic aspect. Cancer 1985; 56;768-776.
25. Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am. J. Surg. Pathol. 1987; 11;418-429.
26. Lippman SM, Grogan TM, Spier CM et al. Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer 1987; 59;936-939.
27. Ng CS, Chan JKC, Lo STH. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum. Pathol. 1987; 18;1257-1262.
28. Hercend T, Schmidt RE. Characteristics and uses of natural killer cells. Immunol. Today 1988; 9;291-293.
29. Gaulard P, Henni T, Marolleau JP et al. Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for a monoclonal T-cell disorder. Cancer 1988; 62;705-710.
30. Lipford EH, Margolick JB, Longo DL, Fauci AS, Jaffe ES. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 1988; 72;1674-1681.
31. Frierson HF, Innes DJ Jr, Mills SE, Wick MR. Immunophenotypic analysis of sinonasal non-Hodgkin's lymphomas. Hum. Pathol. 1989; 20;636-642.
32. Ng CS, Chan JKC, Hui PK, Chan WC, Lo STH. Application of a T-cell receptor antibody betaF1 for immunophenotypic analysis of malignant lymphomas. Am. J. Pathol. 1988; 132;365-371.
33. Weiland LH, McDonald TJ, DeRemee RA. Relationship of polymorphic reticulosis and lymphomatoid granulomatosis. Semin. Respir. Med. 1989; 10;173-177.
34. Ratech H, Burke JS, Blayney DW, Sheibani K, Rappaport H. A clinicopathologic study of malignant lymphomas of the nose, paranasal sinuses and hard palate including cases of lethal midline granuloma. Cancer 1989; 64;2525-2531.
35. Ho FC, Choy D, Loke SL et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum. Pathol. 1990; 21;1041-1050.
36. Ferry JA, Sklar J, Zukerberg LR, Harris NL. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis. Am. J. Surg. Pathol. 1991; 15;268-279.
37. Campo E, Cardesa A, Alos L et al. Non-Hodgkin's lymphomas of nasal cavity and paranasal sinuses. An immunohistochemical study. Am. J. Clin. Pathol. 1991; 96;184-190.
38. Medeiros LJ, Peiper SC, Elwood L, Yano T, Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum. Pathol. 1991; 22;1150-1157.
39. Peiper SC. Angiocentric lymphoproliferative diorders of the respiratory system: incrimination of Epstein-Barr virus in pathogenesis. Blood 1993; 82;687-690.
40. Suzumiya J, Takeshita M, Kimura M et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 1994; 83;2255-2260.
41. de Bruin PC, Jiwa M, Oudejans JJ et al. Presence of Epstein- Barr virus in extranodal T-cell lymphomas: differenced in relation to site. Blood 1994; 83;1612-1618.
42. Nakamura S, Suchi T, Koshikawa T et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract among the Japanese. Am. J. Surg. Pathol. 1994; 19;284-296.
43. Wong KF, Chan JKC, Ng CS, Lee KC, Tsang WYW, Cheung MMC. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum. Pathol. 1992; 23;798-804.
44. Tsang WYW, Chan JKC, Yip TTC et al. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopgaryngeal CH56- positive and D56-negative T-cell lymphomas. Hum Pathol 1994; 25;758-765.
45. Nakamura S, Suchi T, Koshikawa T et al. Aggressive rectal lymphoma of large granular lymphocytes with the histologic feature of an angiocentric growth pattern. Cancer 1993; 71;249-256.
46. Delellis RA, Sternberger LA, Mann RB, Banks PM, Nakane PK. Immunoperoxidase technics in diagnostic pathology. Report of a workshop sponsored ny the National Cancer Institute. Am. J. Clin. Pathol. 1979; 71;483-488.
47. Sasajima Y, Yamabe H, Kobashi Y, Hirai K, Mori S. High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas. Am. J. Pathol. 1993; 143;1280-1285.
48. Higuchi R. Rapid efficient DNA extraction for PCR from cells or blood. Perkin Elmer Cetus Amplifications 1990; 2;1-3.
49. Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patient with Sjogren's syndrome. J. Exp. Med. 1989; 169;2191-2198.
50. Brousset P, Butet V, Chittal S, Selves J, Delsol G. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody. Lab. Invest. 1992; 67;457-464.
51. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1988; 318;733-741.
52. Wu TC, Mann RB, Epstein JI et al. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma, a morphologically distinctive target for detection of Epstein-Barr virus in formalin fixed paraffin-embedded carcinoma specimens. Am. J. Pathol. 1991; 138;1461-1469.
53. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn. Mol. Pathol. 1992; 1;246-255.
54. Khan G, Coates PJ, Kangro HO, Slavin G. Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridization with oligonucleotide probes. J. Clin. Pathol. 1992; 45;616-620.
55. Ambinder RF, Mann RB. Epstein-Barr-encoded RNA in situ hybridization: diagnostic applications. Hum. Pathol. 1994; 25;602-605.
56. Weiss LM, Chen YY. Effects of different lixatives on detection of nucleic acids from paraffin-embedded tissues by an in situ hybridization using oligonucleotide probes. J. Histochem. Cytochem. 1991; 39;1257-1242.
57. Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunblastic lymphadenopathy-like lymphomas. Blood 1992; 79;1785-1795.
58. Anagnostopoulos I, Hummel M, Finn T et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphomas of angioimmunoblastic lymphadenopathy type. Blood 1992; 80;1804-1812.
59. Berceanu S, Roman S, Butoianu E et al. A particular case of large granular lymphocyte lymphoma. Haematologia 1989; 22;43-53.
60. Imamura N, Kusunoki Y, Kawa-Ha K et al. Aggressive natural killer cell leukemia/lymphoma: report of four cases and the review of the literature. Br. J. Haematol. 1990; 75;49-59.
61. Imashuku S, Okuda T, Yoshihara T, Ikushima S, Hibi S. Cytokine levels in aggressive natural cell leukemia and malignant histiocytosis. Br. J. Haematol. 1991; 79;132-141.
62. Chan WC, Gu LB, Masih A et al. Largo granular lymphocyte proliferation with the natural killer cell phenotype. Am. J. Clin. Pathol. 1992; 97;353-358.
63. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992; 79;2432-2437.
64. Sun T, Schulman P, Kolitz J et al. A study of lymphoma of large granular lymphocytes with modern modalities: report of two cases and review of the literature. Am. J. Hematol. 1992; 40;135-145.
65. Sun T, Brody J, Susin M et al. Aggressive natural killer ceill lymphoma/leukemia. A recently recognized clinicopathologic entity. Am. J. Surg. Pathol. 1993; 17;1289-1299.
66. Young L, Allieri C, Hennesky K et al. Expression of Epstein- Barr virus transformation associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 1989; 321; 1080-1085.
67. Cohen JI, Wang F, Mannick J, Kieff E. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 1989; 86;9558-9562.
68. Wang F, Gregory CD, Sample C et al. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 1990; 64;2309-2318.
69. Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J. Virol. 1992; 66;122-131.